The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.

August 14, 2003 — When evaluating select patients with recurrent unexplained syncope, a diagnostic strategy of prolonged primary monitoring using an implantable loop recorder is more cost effective ...

Wilmington, Delaware, United States, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global implantable loop recorders market was projected to attain US$ 1.3 billion in 2022.

May 10, 2005 (New Orleans) – Implantable loop recorders successfully provided a diagnosis in almost half of patients with unexplained syncope or presyncope, New York researchers reported at the Heart ...

Please provide your email address to receive an email when new articles are posted on . The insertion of an implantable loop recorder in patients with systemic sclerosis and no known heart disease ...

Q: When is the ILR removed? A: ILR is removed once the adequate information is collected. Q: What are the complications? A: It is a safe procedure. Infection, bruising and swelling at the implanted ...

Dublin, Jan. 17, 2025 (GLOBE NEWSWIRE) -- The "Implantable Loop Recorders Market Size, Share & Trends Analysis Report By Activation, By Application, By End Use, By Region, And Segment Forecasts, 2025 ...

Dallas, Texas, Dec. 18, 2020 (GLOBE NEWSWIRE) -- The “Global Implantable Loop Recorders Market Size 2020, By Application (Atrial Fibrillation, Cardiac Arrhythmia, Cardiac Syncope) End Use (Hospitals, ...

DUBLIN--(BUSINESS WIRE)--The "Global Implantable Loop Recorders Market By Application (Atrial fibrillation, Cardiac Arrhythmia and Cardiac syncope), By End User (Hospitals, Cardiac Centers and Other ...